Back to Search
JACK HERSHMAN, M.D.
M.D.
Specialist
NPI: 1750333274IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
151313(NY)
CMS Specialties
PrimaryUROLOGY
Education
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Class of 1981
Research & Publications (20)
Novel treatment of medullary thyroid cancer.
PMID 19633548·Curr Opin Endocrinol Diabetes Obes·2009
6-review
The role of human chorionic gonadotropin as a thyroid stimulator in normal pregnancy.
PMID 18772462·J Clin Endocrinol Metab·2008
8-other
Effect of sunitinib on growth and function of FRTL-5 thyroid cells.
PMID 18578612·Thyroid·2008
7-preclinical
Carbothermal synthesis of carbon-supported nanoscale zero-valent iron particles for the remediation of hexavalent chromium.
PMID 18505003·Environ Sci Technol·2008
8-other
Expression of hepatocyte nuclear factor-1alpha mRNA in human anaplastic thyroid cancer cell lines and tumors.
PMID 18399756·Thyroid·2008
8-other
Thyroid-stimulating hormone increases active transport of perchlorate into thyroid cells.
PMID 18303123·Am J Physiol Endocrinol Metab·2008
7-preclinical
Identification of cyclic adenosine 3',5'-monophosphate response element modulator as an activator of the human sodium/iodide symporter upstream enhancer.
PMID 18202121·Endocrinology·2008
7-preclinical
Indomethacin inhibits cell growth of medullary thyroid carcinoma by reducing cell cycle progression into S phase.
PMID 18791128·Exp Biol Med (Maywood)·2008
8-other
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.
PMID 17904459·Am J Med·2007
2-rct
Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity.
PMID 17465866·Thyroid·2007
8-other
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase.
PMID 17210721·Cancer Res·2007
8-other
Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
PMID 17000694·Clin Cancer Res·2006
7-preclinical
Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells.
PMID 16676400·Thyroid·2006
8-other
Iodide sensitizes genetically modified non-small cell lung cancer cells to ionizing radiation.
PMID 16052231·Cancer Gene Ther·2006
8-other
Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells.
PMID 15486044·Mol Endocrinol·2005
8-other
Perchlorate and thyroid function: what are the environmental issues?
PMID 15929663·Thyroid·2005
6-review
Partial withdrawal of levothyroxine to stimulate serum thyroglobulin for thyroid cancer monitoring.
PMID 15666427·Thyroid·2004
8-other
Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment.
PMID 15299084·Mol Cancer Ther·2004
8-other
Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells.
PMID 15172989·Cancer Res·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 777 N BROADWAY, SUITE 309
SLEEPY HOLLOW, NY 10591 - Phone
- (914) 631-3331
Quick Facts
- NPI
- 1750333274
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile